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ABSTRACT - Purpose: To validate a Stigma Scale of Epilepsy (SSE). Methods: The SSE was completed by
40 adult with epilepsy attending an Outpatient Epilepsy Clinic at the University Hospital of UNICAMP, and
by 40 people from the community. People were interviewed on an individual basis; a psychologist read the
questions to the subjects who wrote the answers in a sheet. The procedure was the same for all the sub-
jects and completion took around ten minutes. Results: The SSE has 24 items. The internal consistency of
the SSE showed  C ro n b a c h ’s coefficient 0.88 for the patients with epilepsy and 0.81 for the community.
The overall mean scores of the Stigma Scale of Epilepsy formula were: 46 (SD=18.22) for patients and 49
(SD=13.25) for the community where a score of 0 would suggest no stigma, and 100 maximum stigma.
Discussion: The SSE has satisfactory content validity and high internal consistency. It allows the quantifica-
tion of the perception of stigma by patients and people from community; this can then be used for inter-
ventional studies, such as mass media campaign in minimizing the negative facets of stigma.
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Escala de estigma na epilepsia: processo de validação 
RESUMO - Objetivo: Validar a Escala de Estigma na Epilepsia (EEE). Método: A EEE foi aplicada em 40
pacientes adultos com o diagnóstico de Epilepsia do Ambulatório de Epilepsia do HC/Unicamp e em 40
pessoas da comunidade em geral. Os sujeitos foram entrevistados individualmente pelas psicólogas, que
foram lendo as questões e anotando as respostas na escala. As condições de aplicação foram as mesmas e
a aplicação durou cerca de 10 minutos.  Resultados: A EEE possui 24 itens. A consistência interna da EEE
mostrou  de Cronbach, de 0,88 para os pacientes com epilepsia e 0,81 para a comunidade. As médias do
valor geral de estigma obtido com a fórmula da EEE foram: 46 (DP=18,22) para os pacientes e 49 (DP=13,25)
para a comunidade. Discussão: A EEE possui uma satisfatória validade e alta consistência interna. Isso
permite uma quantificação da percepção de estigma da epilepsia na comunidade em geral, que pode ser
utilizada para estudos interventivos, como campanhas na mídia, para minimizar as facetas negativas do
estigma na sociedade. 
PA L AV R A S - C H AVE: estigma, epilepsia, criação de instrumento, qualidade de vida, validação, escala de
estigma.
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Epilepsy is a common neurological condition, fre-
quently associated with psycho-social diff i c u l t i e s1 - 3.
P rejudice and discrimination are often worse than
the seizures themselves4,5 in terms of impact on dai-
ly life of people with epilepsy. According to some stu-
dies carried out in Euro p e3 , 5 - 7 and North America8 - 1 1
the stigma of epilepsy is considered one of the most
important negative influences on the quality of life
of people with epilepsy.
Epilepsy is said to be a stigmatizing condition as
people do not conform to social norms as a result of
u n p redictable seizures, and consequently society
d reads dealing with someone who is having an
epileptic seizure1 2. From the patient’s view, the diag-
nosis of epilepsy triggers a change in perc e p t i o n ,
bringing on fears of being diff e rent and anxiety
about the future in the community, with apprehen-
sion about getting a job or starting a family1 3. Per-
ception is often negative, which may impair the pa-
tient’s quality of life and reinforces the stigma13.
It is clear that epilepsy affects behaviour and qual-
ity of life not only for the person who has epilepsy,36 Arq Neuropsiquiatr 2007;65(Supl 1)
but also for the entire family3 , 6 , 1 4 , 1 5. This fact is well
known, but paradoxically this facet of epilepsy is rare l y
studied, especially in developing countries1 6, where
the burden of epilepsy stigma is probably very high.
Stigma is a term frequently used nowadays, but
it is still difficult to conceptualize and measure it. Stu-
d i e s 1 7 - 2 0 p o rtray stigma in somewhat diff e rent per-
spectives, and the results are derived from qualita-
tive assessments. We wish to highlight the import a n-
ce of the study of stigma of epilepsy, emphasizing
that a specific quantitative instrument for its evalu-
ation should be created16.
The process of creation of a scale involves several
methodological steps2 1. In order to elaborate the
Stigma Scale of Epilepsy (SSE), firstly we had to re v i e w
the definition of the attribute, delimitation of the
population and characterization of the item type2 1.
Because of the lack of instruments to evaluate epilep-
sy stigma locally, our first instrument was an explora-
t o ryand open questionnaire with general questions
to patients and lay people from the local community.
To create these questions, we reviewed the literature
and our clinical experience in epilepsy. A panel of thre e
specialists not involved in the project evaluated the
questions, and afterw a rds the most appropriate items
w e re chosen. We interviewed 20 patients and 20 lay
people using an open questionnaire on the global
p e rception of epilepsy and its impact; details are pub-
lished elsewhere2 2. Briefly, the overall result showed
that there is a poor knowledge of epilepsy among
those interviewed, although most of them have
received information from their doctors. In re g a rd to
the social aspects, most of them re f e rred to diff i c u l-
ties in work and school environments and also in
establishing relationships. The main feelings highlight-
ed by patients and relatives about epilepsy were sad-
ness, dependence, inferiority, insecurity, fear and pity.
Based on the results of this first questionnaire2 2,
we reviewed the questions and answers to produce
a closed questionnaire2 3. A multiple-choice question-
n a i re was created and completed by 12 patients and
32 lay people. Based on those answers we selected
the most common (50% cut-off) items for the final
version of SSE. 
In order to overcome the lack of a gold-standard
for internal correlation, we proposed a comparison
of how people perceive other chronic conditions2 4,
which carry different weights of stigma. In this con-
text, we assessed whether there were diff e rences in
stigma perception towards epilepsy and two other
p revalent and chronic conditions, but with distinct
d e g ree of stigma, AIDS and diabetes. The result fro m
145 lay people and 86 patients and relatives showed
that AIDS had the highest level of prejudice and dia-
betes the lowest, and epilepsy was in the middle,
closer to AIDS24.
The objective of this paper is to present the vali-
dation of the Stigma Scale of Epilepsy (SSE). This is
phase III of the Demonstration Project on Epilepsy in
Brazil, part of WHO/ILAE/IBE Global Campaing
Against Epilepsy, executed by ASPE, Assistência à
Saúde de Pacientes com Epilepsia16.
METHOD
Stigma scale of epilepsy - content and scoring – A f t e r
the analysis of results obtained in the previous phases de-
scribed and published elsewhere2 2 - 2 5, the Stigma Scale of
Epilepsy (SSE)2 5 was finalized. It now contains five questions
with twenty-four items, each with a four-point scale: the
individuals were asked to indicate the most appro p r i a t e
answer for that item, marking the number corresponding
to the category (1 not at all, 2=a little, 3=a lot, 4=totally).
Comparative factor in the validation process – For val-
idation purposes, it was necessary to compare to other ques-
tions related to stigma. As described above, we used ques-
tions to compare the perception of  epilepsy with that of
diabetes and AIDS. These questions are:
– What score would you rate for the prejudice that the
general population has towards epilepsy (0=no pre j u-
dice, 10=maximum prejudice)? 
– What score would you rate for the prejudice that the
general population has towards AIDS (0=no pre j u d i c e ,
10=maximum prejudice)? 
– What score would you rate for the prejudice that the
general population has towards diabetes (0=no preju-
dice, 10=maximum prejudice)? 
A further question was asked to give an idea of the dis-
tribution of the stigma scores and the perception of stig-
ma in society:
– Do you believe that people with epilepsy are stigma-
tized or rejected by society? (Yes or No).
In addition, another scale was used in the study - QQV-
65, Questionário de Qualidade de Vida – with 65 ques-
t i o n s 2 6, that evaluates the quality of life of people with
e p i l e p s y, through the following domains: perception of
health, physical limitations, social aspects, satisfaction, per-
ception of control, affective-emotional aspects, self-image,
cognitive aspects, work and leisure. This scale was complet-
ed only by patients to com pare two important aspects in
the daily life of people with epilepsy: stigma and quality
of life. Our prior hypothesis was that there would be a neg-
ative correlation between these aspects.
Sampling and questionnaire administration – The sub-
jects were divided in two groups: 
1 . Patients from the Epilepsy Outpatient Clinic of the
Hospital of State University of Campinas (UNICAMP), SP,
Brazil.Arq Neuropsiquiatr 2007;65(Supl 1) 37
2. People in the community.
All subjects gave informed consent. The study was
a p p roved by the Ethics Committee of UNICAMP (number
064/2002).
Two psychologists (PTF, PCBS) interviewed people on an
individual basis; the question was read by the psychologist
and the subject then wrote down the answers. The form
was the same for all the subjects. 
Plan of analysis – The following statistical tests were
used for scale analysis 27-29:
– Descriptive statistics were used for continuous variables
and frequency for categorical variables.
– C ro n b a c h ’s  c o e fficient for reliability and internal con-
sistency was used for validation and verification of the
consistency of the instrum ent. This coefficient is used
to verify the homogeneity or accuracy of instru m e n t
items. The accuracy should not be lower than 0.80 if
the scale is widely used, although values above 0.60
indicate consistency27.
– Pearson correlation coefficient and Mann-Whitney U
test was applied for analysis of comparative questions
with variables of interest.
– S p e a rm an correlation coefficient was used to corre l a t e
the score of stigma in epilepsy with the QQV-65 score.
The significance level used was 5% (p-value < 0.05).
The items scores from the questionnaire were summed
and the score is linearly transformed onto a 0-100 scale,
with 0 indicating no stigma and 100 indicating highest lev-
el of stigma of epilepsy.
RESULTS
We interviewed 80 subjects (40 patients and 40
people in the community). The main characteristics
of the population studied are shown in Table 1.
Descriptive analyses
Comparative questions – In the group of patients,
the median prejudice score was 7 for epilepsy, 8 for
Table 1. Characteristics of the subjects (80 people=40 patients and 40 people in the community).
Characteristics
Community
n=40 (%)
Patients
n=40 (%)
Mean age 35 39
Gender
Men 13 (32.5%) 17 (42.5%)
Women 27 (67.5%) 23 (57.5%)
Religion
Without religion 7 (17.5%) 2 (5%)
Catholic 24 (60%) 22 (55%)
Evangelical 6 (15%) 14 (35%)
Spiritist 2 (5%) 1 (2.5%)
Others 1 (2.5%) 1 (2.5%)
School level
Illiterate/incomplete elementary school 7 (17.5%) 6 (15%)
Complete elementary school/incomplete high school 24 (60%) 16 (40%)
Complete high school/incomplete college 6 (15%) 4 (10%)
Complete college/incomplete university degree 2 (5%) 12 (30%)
University degree 1 (2.5%) 2 (5%)
Epilepsy’ characteristics  of  patients 
Characteristics Patients n=40 (%)
Mean age of seizure onset  13.69 (0-55)
Mean age of epilepsy diagnosis 17.87 (1-55)
Medical treatment
Yes 40 (100%)
No 0
Seizure type
Partial seizure 10 (27.5%)
Partial seizure with a secondary generalization  24 (57.5%)
Generalized seizure 6 (15%)38 Arq Neuropsiquiatr 2007;65(Supl 1)
AIDS and 5 for diabetes. Non-parametric analysis
showed a diff e re nce among the three groups (Fried-
man[2]=35, p<0.001). For the community group, the
median prejudice score was 7 for epilepsy, 8 for AIDS
and 2 for diabetes. Non-parametric analysis showed
d i ff e rence among the three groups (Friedman[2]=67,
p<0.001). In both situations, Wilcoxon paired analy-
sis corrected for multiple comparison showed signif-
icant diff e rence among the three groups (AIDS>
epilepsy>diabetes). The question “Do you think peo-
ple with epilepsy are stigmatized or rejected by soci-
ety?” showed that 72.5% of the community and
65.0% of the patients believed that people with
epilepsy are stigmatized or rejected by society.
Table 2 shows the subjects’ answers using the scale
from 1 to 4 (range from not at all to totally), which
were then used to calculate a SSE general score. 
The mean and standard deviation (SD) of the total
stigma scores obtained with the Stigma Scale of
Epilepsy formula were: 46, SD=18.22 for patients and
49, SD=13.25 for community (see score instructions).
Descriptive statistics and scaling pro p e rt i e s
Data quality – All the items of the questionnaire
w e re answered. The mean time for completion of
the scale was ten minutes. After completing the scale,
on direct questioning the subjects stated that they
did not have problems understanding the questions.
Only two items had inverted scores (see score instru c-
tions).
Table 2. Stigma scale of epilepsy questions and the results from 40 control subjects and 40 people with epilepsy.
Community n=40 (%) Patients n=40 (%)
Not at all A little  A lot Totally Not at all A little  A lot Totally
Do you think that people with epilepsy feel able to control their own epilepsy?
24 (60.0) 9 (22.5) 7 (17.5) 0 17 (42.5) 11 (27.5) 10 (25.0) 2 (5.0)
How would you feel when you see an epileptic seizure?
Scared 12 (30.0) 4 (10.0) 19 (47.5) 5 (12.5) 13 (32.5) 9 (22.5) 12 (30.0) 6 (15.0)
Fear 26 (65.0) 6 (15.0) 14 (35.0) 6 (15.0) 23 (57.5) 5 (12.5) 10 (25.0) 9 (22.5)
Sadness 9 (22.5) 8 (20.0) 17 (42.5) 6 (15.0) 7 (17.5) 10 (25.0) 15 (37.5) 8 (20.0)
Pity 15 (37.5) 5 (12.5) 14 (35.0) 6 (15.0) 9 (22.5) 12 (30.0) 10 (25.0) 9 (22.5)
Which difficulties do you think people with epilepsy have in their daily lives?
Relationships 18 (45.0) 8 (20.0) 12 (30.0) 2 (5.0) 15 (37.5) 10 (25.0) 13 (32.5) 2 (5.0)
Work 5 (12.5) 4 (10.0) 24 (60.0) 7 (17.5) 6 (15.0) 9 (22.5) 15 (37.5) 10 (25.0)
School 7 (17.5) 9 (22.5) 18 (45.0) 6 (15.0) 7 (12.5) 13 (32.5) 15 (37.5) 5 (12.5)
Friendships 10 (25.0) 9 (22.5) 15 (37.5) 6 (15.0) 13 (32.5) 11 (27.5) 11 (27.5) 6 (12.5)
Sexual 9 (22.5) 14 (35.0) 14 (35.0) 3 (7.5) 17 (42.5) 6 (15.0) 12 (30.0) 5 (12.5)
Emotional 4 (10.0) 5 (12.5) 24 (60.0) 7 (17.5) 6 (10.0) 10 (25.0) 18 (45.0) 6 (15.0)
Prejudice 4 (10.0) 5 (12.5) 18 (45.0) 13 (32.5) 12 (30.0) 12 (30.0) 4 (28.0) 12 (30.0)
How do you think that people with epilepsy feel? 
Worried 4 (10.0) 10 (25.0) 16 (40.0) 10 (25.0) 7 (17.5) 6 (15.0) 14 (35.0) 13 (32.5)
Dependent 5 (12.5) 10 (25.0) 16 (40.0) 9 (22.5) 11 (27.5) 8 (20.0) 10 (25.0) 11 (27.5)
Incapable 21 (52.5) 8 (20.0) 8 (20.0) 3 (7.5) 23 (57.5) 8 (20.0) 3 (7.5) 6 (15.0)
Fearful 7 (17.5) 10 (25.0) 20 (50.0) 3 (7.5) 12 (30.0) 11 (27.5) 13 (32.5) 4 (10.0)
Depressed 6 (15.0) 12 (30.0) 19 (47.5) 3 (7.5) 10 (25.0) 10 (25.0) 9 (22.5) 10 (25.0)
Ashamed 9 (22.5) 9 (22.5) 16 (40.0) 6 (15.0) 15 (37.5) 9 (22.5) 9 (22.5) 7 (17.5)
The same as those without epilepsy 24 (60.0) 8 (20.0) 7 (17.5) 1 (2.5) 20 (50.0) 7 (17.5) 9 (22.5) 3 (7.5)
In your opinion, the prejudice in epilepsy will be related to? 
Relationships 3 (12.5) 12 (30.0) 21 (52.5) 4 (10.0) 8 (20.0) 15 (37.5) 14 (35.0) 3 (7.5)
Marriage 21 (52.5) 7 (17.5) 10 (25.0) 2 (5.0) 15 (37.5) 9 (22.5) 12 (30.0) 4 (10.0)
Work 5 (12.5) 9 (22.5) 19 (47.5) 7 (17.5) 9 (22.5) 9 (22.5) 14 (35.0) 8 (20.0)
School 7 (17.5) 10 (25.0) 18 (45.0) 5 (12.0) 10 (25.0) 7 (17.5) 16 (40.0) 7 (17.5)
Family 19 (47.5) 13 (32.5) 6 (15.0) 2 (5.0) 16 (40.0) 15 (37.5) 6 (15.0) 3 (7.5)Arq Neuropsiquiatr 2007;65(Supl 1) 39
Reliability and validity – Reliability and validity
evaluation: the internal consistency of the SSE for
the score showed a general  C ro n b a c h ’s coeff i c i e n t
was 0.88 for the patients with epilepsy and 0.81 for
people in the community.
Comparative analysis – Table 3 shows Pearson
C o rrelation Coefficients between SSE scores and the
results of the questions “What score would you rate
for the prejudice that the general population has
t o w a rds people with Epilepsy, AIDS and Diabetes
(0=no prejudice, 10=maximum prejudice)?”.
R e g a rding the comparative question “Do you
believe that people with epilepsy are stigmatized or
rejected by society? (yes or no)”, the median SSE score
of patients that believe that people with epilepsy are
stigmatized or rejected is 53, which is higher than
the median SSE scores (38) of patients who don’t be-
lieve it (Mann Whitney U test, p=0.01). Similarly, the
median SSE score of people from the community who
believe that people with epilepsy are stigmatized or
rejected is 53, which is higher than the median SSE
s c o res (36) of people who don’t believe it (Mann
Whitney U test, p=0.006). 
The Quality of Life and Stigma are also corre l a t-
ed. Table 4 shows Spearman Correlation Coeff i c i e n t s
of the SSE score in comparison with the QQV-65 in-
s t rument. Figure 1 shows the relation between score
of Stigma Scale of Epilepsy and score of QQV-65.
DISCUSSION
SSE is one of the first instruments that allows
quantification of stigma in epilepsy expressed as a
scale. The questions of SSE have a satisfactory con-
tent validity and high internal consistence. It com-
plies with the main re q u i rements of a validation pro c-
e s s 2 1, offering reliable measurements of stigma in
epilepsy.
The choice of any evaluation scale is dependent
on it being a measuring instrument, so that the an-
swers can be ord e red,to produce a numerical corre-
l a t i o n 2 1. Numerical scales are easy to analyze, allow-
ing assessment of high numbers of subjects in an ob-
jective manner21.
The process of validation of the SSE followed
s t a n d a rds recommended for the preparation of sca-
Table 3. Pearson’s correlation with comparative questions and the SSE score.
Comparative questions
Epilepsy AIDS Diabetes
Patients Community Patients Community Patients Community
R P R P R P R P R P R P
0.3018 0.0655 0.3353 0.0344 0.0711 0.6713 0.0997 0.5402 0.0119 0.9443 0.0463 0.7764
R, Pearson’s correlation coefficient; P, p-value. The scores rated for the prejudice that the general population has towards epilepsy, AIDS and diabetes
(0=no prejudice, 10=maximum prejudice) when correlated for SSE score showed in overall a significant correlation only with epilepsy but not with
AIDS or diabetes.
Table 4. SSE score correlated with the seven domains of qual-
ity of life questionnaire (QQV-65).
Domains of quality of life (QQV-65)
in comparison to SSE score
R p
Health –0.59942 <.0001
Physical 0.39957 0.0106
Social –0.41402 0.0079
Emotional –0.52575 0.0005
Control –0.32310 0.0420
Concept –0.49052 0.0013
Cognition –0.37323 0.0177
Total –0.52245 0.0005
R, Spearm a n ’s correlation coefficient; P, p-value; SSE, showed a nega-
tive linear correlation with the domains of quality of life. Fig 1. Comparison between stigma score (SSE) and quality of
life (QQV-65). There is a significant negative correlation bet -
ween the SSE score (x-axis) and quality of life (y-axis).40 Arq Neuropsiquiatr 2007;65(Supl 1)
l e s 3 0 - 3 2, which involved two components: one concep-
tual and another empirical. The conceptual compo-
nent is the assessment of the researcher of whether
the instrument actually measures what it should me-
a s u re. It is a subjective evaluation, with statistical
methods. The operational validation involves an ana-
lysis of statistical methods, usually by comparing with
gold-standard criteria, if available. 
The results of the comparative questions re p l i c a t-
ed our previous finding2 4, that there exists a diff e r-
ence in the stigma perception of chronic diseases such
as epilepsy, AIDS and diabetes. AIDS had the highest
level of stigma and diabetes, the lowest. Epilepsy was
in the intermediate position but close to AIDS. The
stigma measured by SSE appeared to be specific for
epilepsy in the analysis of correlation with these ques-
tions. Furt h e rm o re, the results of a comparative ins-
t rument, QQV-65, completed by patients with epilep-
sy in relation with SSE also showed significant neg-
ative correlations to QQV-65, and showing that the
higher the stigma score, the lower is the quality of
life.
We believe that the reactions of patients and fam-
ily members faced with epilepsy, as well as emotion-
al and individual aspects of each person, re i n f o rc e
i n a p p ropriate discriminatory behaviors3 3 - 3 6. Negative
attitudes on the part of family and friends, in addi-
tion to difficulties in interpersonal relationships,are
factors that perpetuate stigma in society3 3. The are a s
most affected by epilepsy observed in this study re l a t e
to difficulties at work, at school and in social inter-
action, activity restriction and negative feelings by
patients.
In summary, we believe that the SSE is ready to
be used and opens new prospects in the study of stig-
ma in epilepsy as it allows objective quantification
that can be used to assess intervention campaigns
and cross cultural evaluation on this subject. The SSE
can be used to provide quantitative data of the mag-
nitude of the stigma perception of epilepsy in our
society.
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